Search Within

Shari Goldfarb

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (29)
  2. Journal Article (11)
Groups
  1. Biostatistics Service (40)
  2. Breast Medicine Service (40)
  3. Department of Medicine (40)
  4. Epidemiology and Biostatistics (40)
  5. Health Outcomes Research Group (40)
  6. Population Sciences Research Program (40)

More Groups

People
  1. Sujata Patil (34)
  2. Clifford Hudis (19)
  3. Maura Dickler (19)
  4. Diana Lake (13)
  5. Gabriella D'Andrea-Carlino (13)
  6. Shanu Modi (13)

More People

Years
  1. 2024 (2)
  2. 2023 (2)
  3. 2021 (3)
  4. 2020 (2)
  5. 2019 (3)
  6. 2018 (1)

More Years

Publications
  1. Journal of Clinical Oncology (16)
  2. Cancer Research (9)
  3. Annals of Surgical Oncology (2)
  4. Breast Cancer Research and Treatment (2)
  5. Clinical Breast Cancer (2)
  6. International Journal of Radiation Oncology, Biology, Physics (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (16)
  2. American Association for Cancer Research (9)
  3. Elsevier Inc. (6)
  4. Springer (4)
  5. American Medical Association (1)
  6. Elsevier Science, Inc. (1)

More Publishers

Results (40)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The CHANCE study: Persistent hair disorder-related quality of life in women with nonmetastatic breast cancer
    Meeting Abstract

    Phillips, G. S.; Freites-Martinez, A.; Patil, S.; Samuels, A.; Shapiro, J.; Kukoyi, O.; Goldfarb, S.; Lacouture, M. E.
    Journal of the American Academy of Dermatology (2019)

    Fulltext@MSK | Save
  • The CHANCE study: Mechanical skin changes among women with non-metastatic breast cancer receiving chemotherapy and endocrine therapy
    Meeting Abstract

    Lacouture, M. E.; Phillips, G. S.; Freites-Martinez, A.; Patil, S.; Samuels, A.; Shapiro, J.; Kukoyi, O.; Goldfarb, S.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • The CHANCE study: A prospective, longitudinal study of chemotherapy and hormonal therapy induced hair changes and alopecia, skin aging and nail changes in women with non-metastatic breast cancer
    Meeting Abstract

    Lacouture, M. E.; Freites-Martinez, A.; Patil, S.; Samuels, A.; Shapiro, J.; Ciccolini, K.; Kukoyi, O.; Goldfarb, S. B.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Surgical ovarian ablation for hormone receptor positive primary breast cancer in premenopausal women
    Meeting Abstract

    Oseledchyk, A.; Gemignani, M.; Dickler, M. N.; Goldfarb, S. B.; Iasonos, A.; Zhou, Q.; Carter, J.; Barakat, R. R.; Abu-Rustum, N.; Zivanovic, O.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Fertility preservation for the young breast cancer patient
    Journal Article

    Goldfarb, S. B.; Kamer, S. A.; Oppong, B. A.; Eaton, A.; Patil, S.; Junqueira, M. J.; Olcese, C.; Kelvin, J. F.; Gemignani, M. L.
    Annals of Surgical Oncology (2016)

    Fulltext@MSK | Save
  • A pilot study of dose-dense paclitaxel with trastuzumab and lapatinib for node-negative HER2-overexpressed breast cancer
    Journal Article

    Iyengar, N. M.; Fornier, M. N.; Sugarman, S. M.; Theodoulou, M.; Troso-Sandoval, T. A.; D'Andrea, G. M.; Drullinsky, P. R.; Gajria, D.; Goldfarb, S. B.; Comen, E. A.; more...
    Clinical Breast Cancer (2016)

    Fulltext@MSK | Save
  • Phase I study of PI3Kα inhibitor BYL719 + aromatase inhibitor (AI) in patients (pts) with hormone receptor-positive (HR+) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Moynahan, M. E.; Modi, S.; Hamilton, N.; Caravella, B. A.; Zamora, S.; Dang, C.; Gilewski, T.; Traina, T.; Comen, E.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • The impact of adjuvant breast cancer (BC) chemotherapy on ovarian reserve and menses
    Meeting Abstract

    Goldfarb, S. B.; Bedoschi, G.; Grunblatt, E.; Goswami, S.; Cigler, T.; Quistorff, J.; Pacheco, F.; Stobezki, R.; Robson, M. E.; Moy, F.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase I trial: PI3Kα inhibitor BYL719 plus aromatase inhibitor (AI) for patients with hormone receptor-positive (HR+) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Moynahan, M. E.; Modi, S.; Caravella, B. A.; Datko, F. M.; Zamora, S.; Comen, E.; Gilewski, T.; Sugarman, S. M.; D'Andrea, G.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • A prospective longitudinal study of the impact of breast cancer treatment with adjuvant chemotherapy or tamoxifen alone on ovarian reserve
    Meeting Abstract

    Goldfarb, S. B.; Bedoschi, G.; Grunblatt, E.; Goswami, S.; Cigler, T.; Quistorff, J.; Pacheco, F.; Stobezki, R.; Robson, M.; Moy, F.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save